Company Profile

Yino Pharma Limited
Year Established : 2009
Main Competitive Advantages : International Approvals/Standards,Experienced R&D Staff,Production Capacity,Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages : Traceability, Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site.
  • Contact Person :
  • Fax:
Yino Pharma Limited is closed loop EU-GMP certified producer of Heparin range Anticoagulants: Heparin Sodium (EU-GMP), Heparin Calcium (EU-GMP), Enoxaparin Sodium(EU-GMP), Nadroparin Calcium(EU-GMP), Dalteparin Sodium(EU-GMP).Dermatan Sulfate, Heparinoid Sodium and Mucopolysaccharide Polysulfate. Further Heparin derivatives under development. Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site. Additional facility for biological active substances: Chondroitin Sulfate, Liver Extract, Pancreatin, Lung Surfactant.
PharmaSources Customer Service